Loading…

Dose escalation intensity-modulated radiotherapy–based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma

No studies have investigated the effects of irradiation-dose escalation intensity-modulated radiotherapy (IMRT)-based concurrent chemoradiotherapy (CCRT) in patients with thoracic esophageal squamous cell carcinoma (TESCC). We analyzed data from patients with TESCC who were enrolled in the Taiwan Ca...

Full description

Saved in:
Bibliographic Details
Published in:Radiotherapy and oncology 2017-10, Vol.125 (1), p.73-79
Main Authors: Chang, Chia-Lun, Tsai, Hsieh-Chih, Lin, Wei-Cheng, Chang, Jer-Hwa, Hsu, Han-Lin, Chow, Jyh-Ming, Yuan, Kevin Sheng-Po, Wu, Alexander T.H., Wu, Szu-Yuan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:No studies have investigated the effects of irradiation-dose escalation intensity-modulated radiotherapy (IMRT)-based concurrent chemoradiotherapy (CCRT) in patients with thoracic esophageal squamous cell carcinoma (TESCC). We analyzed data from patients with TESCC who were enrolled in the Taiwan Cancer Registry database. To compare treatment outcomes, the patients were categorized into two groups according to their radiotherapy doses: group 1, who received CCRT
ISSN:0167-8140
1879-0887
DOI:10.1016/j.radonc.2017.08.025